Dana-Farber/Harvard Cancer Center Ovarian Cancer Symposium
We invite you and members of your laboratory or clinical unit to attend the second annual Dana-Farber/Harvard Cancer Center Ovarian Cancer Symposium
Friday, April 3, 7:30 a.m. to 3:45 p.m.
Harvard Club (374 Commonwealth Ave), Boston
RSVPs required by 5 p.m., Thursday, March 26
The symposium will provide an opportunity for DF/HCC ovarian cancer researchers to present and discuss their research.
Presentations by Michael Birrer, MD, PhD and Ronny Drapkin, MD, PhD
Sessions on Drug Sensitivity and Resistance; Epidemiology, Risk, and Biomarkers; Imaging and Novel Therapies; Cell Biology and Signaling
The symposium is offered without charge to all DF/HCC ovarian cancer researchers and is made possible by support provided by the DFCI Women's Cancers Program. Advance registration is required and includes the program, continental breakfast, lunch, and monograph of DF/HCC ovarian cancer 2009 abstracts. Seating is limited, and RSVPs are required by Thursday, March 26, 5 p.m. If you plan to attend, please confirm your attendance to Katie Tassi at email@example.com so that we can plan accordingly.
Parking is available for $25 in the Harvard Club lot, and the Club is accessible by public transportation and the M2 MASCO shuttle. For directions or other Club information, see www.harvardclub.com.
An agenda and a list of abstracts is attached. We look forward to having you join us. Please share this email with post-docs and faculty in your area and encourage them to attend. You are also welcome to forward the names of attendees from your unit or laboratory to Katie Tassi at email above.
Ursula Matulonis, MD, and Symposium Co-Chairs: Ross Berkowitz, MD, Mike Birrer, MD, PhD, Steve Cannistra, MD, Dan Cramer, MD, Ronny Drapkin, MD, PhD, Dirk Iglehart, MD, and Carolyn Krasner, MD